Euclises Pharmaceuticals
PrivateLast Round
Series A
Extension
Apr 7, 2015
Total Funding Raised
$3.48M
Company Overview
Euclises Pharmaceuticals is a biotechnology company that develops novel COX-2 inhibitors for the treatment of oncology patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Euclises Pharmaceuticals Comparables
Compare Euclises Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Owkin | 73% | |
| Yiviva | 71% | |
| Kainova Therapeutics | 70% | |
Euclises Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 7, 2015 | ||||
| Series A | Sep 9, 2014 | ||||
| Seed | Jun 11, 2012 |
Euclises Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivation Capital | Series A Extension, Series A |
| Missouri Technology Corporation | Series A |
| St. Louis Arch Angels | Series A Extension, Seed, Series A |
| BioGenerator Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2024
Monthly visitors increased 60% MoM.
- Apr 7, 2015
$2M round with BioGenerator Ventures and Cultivation Capital.
Euclises Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Euclises Pharmaceuticals's valuation, stock price, and market status.